MedTrace Logo

Perpetual Observational Study - Ventilator Associated Pneumonia

NCT05719259 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-04-15

No results posted yet for this study

Summary

Ventilator-Associated Pneumonia (VAP) is a bacterial respiratory infection that patients in the Intensive Care Unit (ICU) often get when they cannot breathe for themselves and require mechanical ventilation. It is linked to higher chances of death, a longer stay in the hospital, higher costs, and the use of more antibiotics.

Options to help prevent or treat this disease are in development and will require evaluation in future clinical trials.

The goal of POS-VAP is to build and continuously train a network of ICUs to be prepared for doing these trials, to facilitate their execution.

Conditions

  • Ventilator Associated Pneumonia

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dupuytren de Limoges (CHUL)

    collaborator UNKNOWN

  • Université de Genève (UNIGE)

    collaborator UNKNOWN

  • University Medical Center Utrecht (UMCU)

    collaborator UNKNOWN

  • European Clinical Research Alliance for Infectious Diseases (ECRAID)

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-03
Primary Completion
2025-12-01
Completion
2026-03-01

Countries

  • Albania
  • Belgium
  • Croatia
  • Czechia
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Romania
  • Serbia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05719259 on ClinicalTrials.gov